Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Diabetes, Obesity & Metabolism|April 20, 2022
Combined therapy with CD4+ CD25highCD127- T regulatory cells and anti-CD20 antibody in recent-onset type 1 diabetes is superior to monotherapy: Randomized phase I/II trialMaciej Zieliński, Magdalena Żalińska, Dorota Iwaszkiewicz-Grześ, et al.
European Journal of Endocrinology|October 15, 2020
Rare CNVs provide novel insights into the molecular basis of GH and IGF-1 insensitivityEmily Cottrell, Claudia P Cabrera, Miho Ishida, et al.
Journal of Translational Medicine|December 2, 2016
Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetesNatalia Marek-Trzonkowska, Małgorzata Myśliwiec, Dorota Iwaszkiewicz-Grześ, et al.
BMJ Open Diabetes Research & Care|February 27, 2020
Proinsulin-specific T regulatory cells may control immune responses in type 1 diabetes: implications for adoptive therapyMateusz Gliwiński, Dorota Iwaszkiewicz-Grześ, Anna Wołoszyn-Durkiewicz, et al.
JCI Insight|January 9, 2024
Mechanisms of thyrotropin receptor-mediated phenotype variability deciphered by gene mutations and M453T-knockin modelKristiina Makkonen, Meeri Jännäri, Luís Crisóstomo, et al.
Endokrynologia Polska|October 24, 2018
Treatment of severe primary IGF-1 deficiency using rhIGF-1 preparation - first three years of Polish experienceElżbieta Petriczko, Tomasz Jackowski, Anita Horodnicka-Józwa, et al.
Pageof 16